依达拉奉治疗急性脑梗死疗效观察

Clinical observation of Edaravone in treatment of acute cerebral infarction

目的:观察依达拉奉治疗急性脑梗死的临床疗效及安全性。方法:将85例急性脑梗死患者随机分为治疗组(43例)及对照组(42例)。两组均予常规治疗,治疗组在此基础上加用依达拉奉。评价两组的治疗效果及治疗前后临床神经功能缺损程度评分变化。治疗组总有效率高于对照组(P<O.05),神经功能缺损评分低于对照组(P<0.05)。结论:依达拉奉治疗急性脑梗死疗效确切,无严重不良反应,可在临床中推广使用。

Objective：To observe the clinical effect and safety of Edaravone in treatment of patients with acute cerebral infarction（ACI）.Methods：85 ACI patients were randomly divided into the treatment group（43 cases） and control group（42 cases）.Patients of the two groups were cured with conventional therapy.On this basis,Edaravone was added to the treatment group.The clinical effect and the clinical nerve deficiency scale were evaluated in the two groups before and after treatment.Results：The effective rate in treatment group was higher than that in control group,there was a significant difference in the two groups（P〈0.05）.The scores of the clinical nerve deficiency scale in treatment group was lower than that in control group（P〈0.05）.Conclusion：Edaravone has higher curative effect in treatment of patients with ACI and has no serious adverse reactions.It is worthy to be recommended for clinical application.